Consent for Molecular Profiling

As part of your cancer care plan, your physician has ordered molecular testing from Caris Life Sciences in order to better understand your tumor’s biomarkers and help identify changes that control cell growth. Results from this test may help guide your personal treatment plan. In order to begin testing, patient consent for molecular profiling is required. Please complete the electronic consent form by clicking the button below.

Fighting Cancer Smarter

Knowing what cancer looks like at the molecular level can lead to better treatment options.

Patient Stories

Learn how others have benefited from Caris molecular profiling.


For questions about Caris molecular profiling please contact us.